Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.365 USD | -0.42% | -3.24% | +128.69% |
13/05 | Oppenheimer Adjusts Mind Medicine Price Target to $20 From $29, Maintains Outperform Rating | MT |
08/05 | Transcript : Mind Medicine Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+128.69% | 604M | |
+59.34% | 62.59B | |
-2.64% | 41.18B | |
+44.25% | 40.29B | |
-8.29% | 27.9B | |
+12.68% | 26.21B | |
-21.73% | 19.09B | |
+5.95% | 13.08B | |
+24.29% | 12.26B | |
+27.24% | 12.05B |
- Stock Market
- Equities
- MNMD Stock
- News Mind Medicine (MindMed) Inc.
- Transcript : Mind Medicine Inc., Q2 2022 Earnings Call, Aug 11, 2022